NCT00344435View on ClinicalTrials.gov

Genetic Susceptibility to Factor VIII Inhibitors

CompletedOBSERVATIONAL

Enrollment

1,187

Participants

Timeline

Start Date

May 24, 2005

Study Completion Date

April 5, 2016

Conditions

Hemophilia

Trial Locations (1)

Unknown

University Hospital, University of Lund, Malmo

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00344435 - Genetic Susceptibility to Factor VIII Inhibitors | Biotech Hunter | Biotech Hunter